ArticleActa neurologica Belgica2026
Brain morphometric alterations along the visual pathway in nonarteritic anterior ischemic optic neuropathy: a voxel-based morphometry study.
Article in Acta neurologica Belgica, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
purposeTo investigate brain morphometric changes in patients with non-arteritic anterior ischemic optic neuropathy (NAION) using voxel-based morphometry (VBM) and to explore their associations with structural and functional ophthalmic parameters.
methodsThis retrospective, cross-sectional study included 15 patients with NAION and 15 healthy controls. All participants underwent high-resolution 3.0-Tesla brain magnetic resonance imaging. Whole-brain VBM was performed using the Computational Anatomy Toolbox (CAT12) implemented in Statistical Parametric Mapping (SPM12) to assess gray and white matter volume differences between groups. Ophthalmic evaluation included best-corrected visual acuity, visual field mean deviation, retinal nerve fiber layer thickness, and ganglion cell-inner plexiform layer thickness measured by optical coherence tomography. Correlation analyses were performed to evaluate the relationships between brain morphometric measures and ophthalmic parameters.
resultsCompared with controls, patients with NAION exhibited reduced gray matter volumes in the limbic lobe, cuneus, occipital lobe, temporal lobe, middle temporal gyrus, parietal lobe, and frontal lobe at an exploratory voxel-level threshold (p < 0.001, uncorrected). Increased gray matter volumes were observed in the bilateral cerebellum, while increased white matter volumes were identified in the right cerebellum and posterior cerebellar lobe. No significant correlations were identified between brain morphometric measures and ophthalmic parameters, time since onset, or visual function (all p > 0.05). None of the observed gray or white matter clusters remained statistically significant after family-wise error (FWE) correction for multiple comparisons.
conclusionsPreliminary evidence suggests that patients with NAION may exhibit brain morphometric alterations involving visual pathway-related cortical regions and the cerebellum. These exploratory findings raise the possibility that central nervous system changes in NAION may extend beyond isolated optic nerve pathology. However, because none of the observed clusters survived family-wise error (FWE) correction for multiple comparisons, these findings should be considered exploratory and require confirmation in larger studies.
Indexed as
Identifiers
42547714What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.